How to Optimize Allergy Billing and Reduce Claim Denials

Why Allergy Billing Behaves Differently

Four things set this specialty apart, and nearly every recurring denial traces to one of them. Preparing the antigen and injecting it are separate billable events, so a practice billing only the injection leaves money behind. Almost everything is unit-based, which means an incorrect count accounts for an incorrect claim submission itself. The same patient returns fifty times a year, so errors are compounded rather than staying isolated. And practices that buy biologics carry inventory costs before any payer has agreed to anything. Practices dealing with the wider set of reimbursement challenges will recognize some of this, though the combination is particular to Allergy and Immunotherapy.

Eligibility Verification Before the First Injection

Standard eligibility checks confirm an insurance plan is active and give you the copay amount. For Allergy and Immunotherapy, that is not enough, because several plan-level details determine whether a multi-year course gets paid at all, and every one of them is worth knowing about before the patient starts the treatment plan.

• Confirm whether testing needs prior authorization and whether the plan caps antigens per session.
• Re-check whether immunotherapy sits under the medical benefit or has been carved out to pharmacy.
• Ensure whether the plan permits self-administration at home, since that charge is what is billable. Establish the deductible position, because a patient starting in January is required to meet a full deductible on your claims.
  

Getting the Allergy Testing Codes Right

Per Medicare billing and coding guidance for allergy testing, each antigen is one unit, and the number of tests must appear on the claim. Testing is coded by method and billed by the number of tests performed. Percutaneous testing with allergenic extracts uses 95004. Venom testing uses 95017, and testing with drugs or biologicals uses 95018. Intracutaneous testing splits by reaction type rather than dilution. So, 95024 for immediate reactions, 95027 for sequential and incremental testing of airborne allergens, and 95028 for delayed reactions. Patch testing is 95044, photo patch 95052, and ingestion food challenge 95076 and 95079.

The unit rules are where claims fail. Twenty-five percutaneous tests are 95004 with 25 units. Coverage does not exceed two strengths per unique antigen, and histamine and saline controls count as two separate antigens.

Two additional guidelines flag these practices.. When photo patch testing accompanies patch testing, only the photo patch testing is reported. An evaluation and management service on the same day as testing is appropriate only when significant and separately identifiable, with modifier 25 and documentation that stands alone. Modifier 25 is heavily audited in this specialty. Appending it to every testing visit as a matter of habit is exactly the pattern payers look for.

Immunotherapy: Billing the Antigen as Well as the Injection

Codes 95115 and 95117 cover administration of the extract only: 95115 for a single injection and 95117 for two or more. Antigen preparation is billed separately, and code selection matters here. 95144 covers single-dose vials prepared for another provider to administer. 95165 covers multiple-dose vials of single or multiple antigens, which is what inhalant, mold, and food immunotherapy uses.

Venom is not 95165. Stinging insect venom has its own codes, 95145 through 95149 by number of venoms, with 95170 for whole-body extract of biting insects. Preparing venom and billing it under 95165 is a recognized recoupment trigger, and it repeats on every vial.

The dose definition is the most valuable rule in this guide. CMS Billing and Coding Guidance for Allergy Immunotherapy defines a dose for 95165 as a one cc aliquot from a single multidose vial, and caps Medicare billing at ten doses per vial regardless of how many preparations are actually obtained from it. A ten cc vial filled to six cc is billed as six doses.

The same guidance resolves most administration denials. Bill one administration code per date of service with a single unit. Never bill both codes on the same date, and note that neither is payable when the patient self-administers. Where more than one multidose vial is prepared, the medical reason has to be documented. Our piece on immunotherapy billing challenges covers running these programs at scale.

Documentation That Survives an Audit

A lot of allergy billing is quantitative, so a note describing the clinical reasoning perfectly but omitting the numbers will not support the claim. General clinical documentation practices apply, with several specialty-specific additions.

• Number of tests performed, with antigens named rather than summarized as a panel.
• Wheal and flare measurements, recorded consistently across staff and across days.
• The volume each vial was actually filled to, which determines billable doses.
• Doses prepared and the preparation date, which may differ from the administration date.
• Medical necessity wherever multiple vials were prepared.
• For each injection, which vial and dilution was used, and the observation period.
  
  

Consistency across staff matters more here than in most specialties. Two nurses measuring a wheal differently produce inconsistent readings. Structured fields in allergy-specific EHR software leave far less to individual habits.

Biologics and Specialty Medications

Biologics for severe asthma, chronic urticaria, and atopic dermatitis have changed practice economics and introduced financial risk that did not previously exist. A denied claim on an administered biologic is not a small write-off. Decide deliberately between buy-and-bill and specialty pharmacy for each drug and each payer, and put the NDC on the claim with the correct unit of measure alongside the HCPCS code.

Read the waste rules directly. CMS guidance on Part B discarded drugs sets out how discarded amounts are reported on single-dose containers. Site-of-service policies also shift without much warning, and the first sign is usually a denial on a patient treated in your office for two years.

Prior Authorization and Referral Management

Under the CMS Interoperability and Prior Authorization Final Rule, Medicare Advantage organizations, state Medicaid and CHIP fee-for-service programs, and Medicaid and CHIP managed care plans must, from January 1, 2026, decide expedited requests within 72 hours. Standard requests must be worked upon within seven calendar days. Qualified Health Plan issuers on the federal exchanges fall under the rule, but not under those timeframes. Affected payers must also give a specific reason for each denial and publish their prior authorization metrics.

One limit worth knowing is that these provisions cover medical items and services and exclude drugs. Biologic authorizations therefore sit outside the rule entirely. So, the faster timelines will not touch the approvals that cause allergy practices the most trouble. Plan the biologic workflow on the assumption that nothing about it is changing.

In the meantime, keep an authorization tracker with expiry dates rather than relying on memory. An authorization that lapses mid-course turns a covered patient into an uncovered one overnight. Record the number where the biller will find it, and confirm whether it covers the antigen, the administration, or both.

Why Allergy Claims Get Denied

• Unit counts that do not match the documentation, particularly on 95165 and 95004.
• Missing or expired prior authorization, especially on biologics and repeat testing.
• Modifier 25 on an evaluation and management service that was not separately identifiable.
• Both 95115 and 95117 billed on the same date of service.
• Antigen preparation billed without a documented vial fill volume.
• Eligibility that lapsed mid-course, on a patient nobody re-verified.
• Diagnosis codes that do not support medical necessity for the antigens tested.
• Timely filing missed on a claim sitting in a queue.

None of these are complex problems but process-related. For a wider view of the errors that quietly cost practices money, our list of common coding mistakes is a useful companion to this guide.

Reducing Denials Before They Happen

Verify eligibility before every immunotherapy series and re-verify annually. Build the unit calculation into the workflow so that vial fill volume drives the billed dose count. Scrub claims against the rules that govern the Allergy and Immunotherapy specialty. Reconcile antigen inventory against billed doses monthly. And review modifier 25 usage quarterly, before a payer reviews it for you.

Diagnosis coding matters twice over for practices in risk-bearing contracts, since diagnoses feed risk adjustment as well as the immediate claim. Our explainer on HCC coding accuracy sets out how that works for allergy practices new to it.

Good allergy medical billing is largely arithmetic per AAAA. A patient starting immunotherapy comes in weekly through a three-to-six-month build-up, then every two to four weeks for the next three to five years. That's somewhere between sixty and a hundred and thirty encounters from a single patient. A control added at the front end gets applied to every one of them. A defect left there repeats just as often. That is the argument for fixing eligibility and unit capture before anything else. 

Working Denials and Appeals

Work denials weekly rather than monthly. Appeal windows are short, and a denial that sits for four weeks has burned much of its window before anyone has looked at it. Categorize every denial by reason code, because the same denial arriving repeatedly is a message about an upstream process rather than an isolated payer decision.

On appeal, attach the documentation that answers the specific denial. A unit-count denial needs the vial fill record. A medical necessity denial needs the clinical rationale and the testing results behind the antigens selected. Track outcomes by payer, since knowing who overturns tells you where the effort is worth spending.

Where Unit-Count Denials Come From.

In a lot of practices, the vial fill volume sits on a preparation log, the doses prepared are recorded in the clinical note, and the number billed is keyed into the claim by whoever reads both. Three separate records and two transcription steps, which is exactly where unit-count denials come from. When those figures are a single entry that carries through onto the claim, there is nothing left to mistype.



 Meditab's medical billing software is built around recording the allergy doses in a unified place. The same applies to testing. A system that holds wheal and flare in structured fields, keeps antigen names rather than panel labels, and carries the test count onto the claim removes the transcription step where most unit errors begin.

Meditab's AllergyEHR Fits

Meditab’s AllergyEHR has been transforming lives in the healthcare industry for the past three decades. The Skin Test Module records testing in a structured form, which answers the consistency problem described earlier about the same wheal being measured the same way by every member of staff, every day, in a field that carries through to the claim.

The immunotherapy side is where this guide's billing arguments meet the software. Shot schedule templates hold the build-up protocol. Automated reminders go out by email, SMS, or app notification, and missed-shot follow-up catches the patients who drift. That matters commercially as well as clinically. A course runs three to five years on maintenance, and AAAAI notes improvement can take up to twelve months at the maintenance dose. A patient who stops at month eight has paid for the entire build-up and collected almost none of the benefit, and the practice loses every remaining encounter on the schedule.

Automated immunotherapy billing does the dose arithmetic that unit-count denials usually turn on. And because Section 21 of USP 797 took effect in November 2023, the system also has to carry the compounding record: per-vial labeling with patient name, dilution, beyond-use date and storage, plus the training and temperature logs that sit behind it. Beyond-use dating cannot exceed one year, and it stops at the earliest component expiry, which is exactly the kind of date nobody tracks reliably on paper.

Black Book Market Research named Meditab’s allergy EHR as one of its top three allergy EHRs for 2025. An Allergy EHR is best judged on a demonstration that uses your own vial setup and dosing schedules. That will tell you more than any feature list can.

The Numbers Worth Watching

• First-pass clean claim rate.
  The best single indicator of front-end health.
  
  
• Initial denial rate, by reason.
  The distribution matters more than the total.
  
  
• Days in A/R, with the share over 90 days.
  That second figure is where the risk sits.
  
  
• Doses billed per vial prepared.
  An allergy-specific measure. A figure well below your fill volumes suggests underbilling.
  
  
• Net collection rate.
  Collected against what you were contractually entitled to collect. This catches quiet underpayment.
  
  
• Authorization turnaround and expiry.
  How long approvals take by payer, and how many lapse mid-course.
  
  

Treating allergy practice revenue cycle management as a monthly review rather than an annual one finds problems while they are still small. At this claim volume, a defect caught in month one costs a fraction of the same defect caught in month eleven.

Should You Outsource Allergy Billing?

In-house billing works when the practice has a biller who knows this specialty, enough volume to keep them current, and cover for when they are away. The failure mode is not incompetence. It is a single point of knowledge resigning and taking four years of payer-specific judgment with it.

Outsourcing works when the partner has genuine allergy experience with allergy clients. Ask how they handle 95165 unit calculations, how they treat vial fill volumes, and what happens when an authorization expires. A partner who hasn't considered those three questions hasn't billed much allergy.



A hybrid suits many mid-sized practices who keep eligibility and authorization in-house where the clinical context lives, and outsource submission, denial work, and follow-up. Either way, both sides need the same view of the same data, since most friction in a hybrid model comes from two teams looking at different screens.

A Practical Checklist

• Eligibility re-verified for every active immunotherapy patient within twelve months.
• Vial fill volumes recorded, and billed doses reconciled against them.
• Venom preparation billed under 95145 to 95149, never 95165.
• No date of service carrying both 95115 and 95117.
• Modifier 25 usage reviewed and defensible in every instance sampled.
• Medical necessity documented wherever multiple vials were prepared.
• Authorization tracker current, with expiry dates and named owners.
• NDC and unit of measure are correct on every biologic claim.
• Denials worked within seven days of receipt, categorized by reason.
• Timely filing monitored by payer, with an alert before the window closes.

Where to Start

If you take one thing from this guide,  make it the dose calculation. Check that your billed units for 95165 match the volume your vials were actually filled to, across twenty patients, this week. Practices are roughly as likely to have been underbilling as overbilling, and both are worth knowing about. After that, work backward through the front end, because allergy immunology medical billing is repetitive work that has to be done identically every time. That is what systems like Meditab’s Allergy EHR is good at, and what people, over thousands of repetitions, are not.

Frequently Asked Questions